Skip to main content
CivicGate

← Organizations

Faegre Drinker Biddle & Reath LLP

lobbying firm

Faegre Drinker Biddle & Reath LLP's federal footprint as a lobbying firm — reported lobbying it billed or handled on behalf of the clients it represents (this is the firm's reported revenue for that work, not its own spending). Figures are as reported to the U.S. Senate (LDA).

Lobbying from Senate LDA

Reported lobbying billed / handled $14,737,300
Firm activeFY2022–FY2026

Reported country: 🇺🇸 United States

Lobbying over time

Reported lobbying for Faegre Drinker Biddle & Reath LLP per filing year
FYLobbying billed / handled (as firm)
2022$4,235,000
2023$3,650,000
2024$2,960,300
2025$3,882,000
2026$10,000

Reported lobbying revenue for the clients Faegre Drinker Biddle & Reath LLP represents — not the firm's own spending.

Clients represented

  • Wholesale & Specialty Insurance Association $1,050,000 · 18 filings
  • Ata Action $940,000 · 14 filings
  • Alliance For Safe Online Pharmacies (Asop Global) $910,000 · 16 filings
  • Shirley Ryan Abilitylab $630,000 · 16 filings
  • The Rehabilitation Innovation Centers Coalition $600,000 · 16 filings
  • Dmg Mori Federal Services $585,000 · 14 filings
  • Boston Children'S Hospital $520,000 · 17 filings
  • Ssm Health $520,000 · 16 filings
  • Parent Project Muscular Dystrophy $460,000 · 21 filings
  • National Association Of Boards Of Pharmacy $460,000 · 16 filings

Clients Faegre Drinker Biddle & Reath LLP filed lobbying for, by reported amount billed/handled.

Issues

Issue area Worked
Health Issues 355
Medicare/Medicaid 165
Budget/Appropriations 134
Pharmacy 55
Science/Technology 34
Manufacturing 30
Education 29
Consumer Issues/Safety/Products 19
Defense 19
Food Industry (safety, labeling, etc.) 19
Taxation/Internal Revenue Code 19
Insurance 18
Telecommunications 16
Urban Development/Municipalities 15
Labor Issues/Antitrust/Workplace 13
Alcohol and Drug Abuse 12
Energy/Nuclear 12
Trade (domestic/foreign) 12
Disaster Planning/Emergencies 10
Government Issues 10
Environment/Superfund 9
Transportation 8
Medical/Disease Research/Clinical Labs 7
Copyright/Patent/Trademark 6
Fuel/Gas/Oil 4
Retirement 4
Chemicals/Chemical Industry 3
Immigration 2
Roads/Highway 2
Agriculture 1

Issue areas across Faegre Drinker Biddle & Reath LLP's filings, by activity count. Linked areas open the CivicGate issue page.

What they lobbied on

Reported activity from Senate LDA

  • FY2026 Budget/Appropriations

    Supporting Congressionally-Directed spending request.

  • FY2026 Defense

    Communications with Congresswomans office that represents the company in NY state to ask for support of their Department of War Office of Strategic Capital application

  • FY2025 Budget/Appropriations

    Enhance funding for WIOA reauthorization; Encourage funding for unseen populations; Increase flexibility in funding allocations to tailor training programs based on local needs and employer demand; Ensure Local Workforce Development Boards (WDBs) have a steady stream of funds to expand programs.

  • FY2025 Environment/Superfund

    Final Rule under the American Innovation and Manufacturing Act.

  • FY2025 Budget/Appropriations

    FY 26 appropriations programmatic and report provisions impacting Inflammatory Bowel Disease public health, medical research and therapy development initiatives.

  • FY2025 Health Issues

    Nutrition issues pertaining to Make America Healthy Again agenda and the Office of Nutrition Research strategic plan; Safe Step Act (H.R. 5509); Congressional Crohn's & Colitis Caucus.

    H.R. 5509

  • FY2025 Health Issues

    Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery

  • FY2025 Retirement

    Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery

Show 52 more activities

  • FY2025 Medicare/Medicaid

    Access to Genetic Counselor Services Act; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.

  • FY2025 Health Issues

    Change to NIH calculation of F&A rates; National Institutes of Health policies pertaining to child health research including opportunities to address childhood chronic diseases and opportunities within the Make America Healthy Again report and strategy; Reauthorization of Small Business Innovation Research/Small Business Technology Transfer programs.

  • FY2025 Budget/Appropriations

    Proposed changes to indirect cost model; Proposed changes to allocation of funding for multi-year awards

  • FY2025 Health Issues

    The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.

  • FY2025 Fuel/Gas/Oil

    Renewable Fuel Standard compliance

  • FY2025 Health Issues

    Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.

  • FY2025 Budget/Appropriations

    Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.

  • FY2025 Medicare/Medicaid

    Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.

  • FY2025 Defense

    Topics likely to include Medicaid, pediatric medical research, government funding, and coverage of children within the Tricare program, among others.

  • FY2025 Food Industry (safety, labeling, etc.)

    Food issues; Issues related to natural cheese; H.R. 1394/S.184, the Codifying Useful Regulatory Definitions Act (CURD) Act; H.R. 1394 / S. 184, the Codifying Useful Regulatory Definitions Act.

    H.R. 1394 S. 184

  • FY2025 Health Issues

    Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).

  • FY2025 Medicare/Medicaid

    Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).

  • FY2025 Taxation/Internal Revenue Code

    S. 653/H.R. 2062: The Health Care Sharing Ministry Tax Parity Act; budget reconciliation

    S. 653 H.R. 2062

  • FY2025 Health Issues

    Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.

    S. 2544

  • FY2025 Retirement

    Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.

    S. 2544

  • FY2025 Medicare/Medicaid

    Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.

    S. 2544

  • FY2025 Taxation/Internal Revenue Code

    S. 653/H.R. 2062: The Health Care Sharing Ministry Tax Parity Act; H.R. 1/OBBB budget reconciliation and possible reconciliation 2.0 opportunities; IRS issues pertaining to sharing ministries.

    S. 653 H.R. 2062 H.R. 1

  • FY2025 Budget/Appropriations

    Congressionally Directed Spending request; Federal funding for employment training and other services.

  • FY2025 Health Issues

    FY 2026 Appropriations, Reconciliation

  • FY2025 Health Issues

    Medical research, FDA regulatory, Public health, Medicaid

  • FY2025 Consumer Issues/Safety/Products

    Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).

    S. 652

  • FY2025 Pharmacy

    Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).

    S. 652

  • FY2025 Health Issues

    Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).

    S. 652

  • FY2025 Telecommunications

    Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).

    S. 652

  • FY2025 Budget/Appropriations

    Issues related to AbilityOne program

  • FY2025 Health Issues

    Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.

    S. 2544

  • FY2025 Retirement

    Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.

    S. 2544

  • FY2025 Medicare/Medicaid

    Home and Community-Based Services (HCBS); Medicaid; Social Security; Medicaid Estate Recovery; Older Americans Act Reauthorization; Elder Justice Act; SNAP funding; GUARD Act (S. 2544); Administration for Community Living funding.

    S. 2544

  • FY2025 Health Issues

    Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.

  • FY2025 Medicare/Medicaid

    Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.

    H.R. 1

  • FY2025 Budget/Appropriations

    FY 26 primary immunodeficiency research and public health funding.

  • FY2025 Budget/Appropriations

    Pell grant, higher education funding

  • FY2025 Health Issues

    Funding and policy matters impacting COPD; FY 2026 Appropriations Reconciliations.

  • FY2025 Health Issues

    Funding for biomedical research and changes to NIH F&A rate calculations. Make America Healthy Again commission and related policy issues pertaining to the transition.

  • FY2025 Medicare/Medicaid

    Accelerating Kids' Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation.

    H.R. 1509 S. 752

  • FY2025 Science/Technology

    Science publishing policies

  • FY2025 Health Issues

    Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.

  • FY2025 Medicare/Medicaid

    Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.

    H.R. 1

  • FY2025 Budget/Appropriations

    FY 26 primary immunodeficiency research and public health funding.

  • FY2025 Health Issues

    Pharmacy Benefit Manager (PBM) reform legislation; legislation pertaining to PBM ownership models; Trump Rx initiative

  • FY2025 Medicare/Medicaid

    Issues pertaining to Transparency in Coverage regulations

  • FY2025 Health Issues

    NIH, CDC, FDA, and DOD issues and funding relating to muscular dystrophy research and programs.

  • FY2025 Health Issues

    The Healthy Brains Act and Appropriations.

  • FY2025 Medicare/Medicaid

    Access to Genetic Counselor Services Act; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.

  • FY2025 Medicare/Medicaid

    Public Law 117-341, the Dr. Joanne Smith Memorial Rehabilitation Innovation Centers Act of 2022.

  • FY2025 Health Issues

    S.1101/H.R. 2332, the SHARE Act; 340B program policy issues; SUD and behavioral health treatment policies; rural healthcare policies; issues pertaining to FEMA reimbursement.

    S. 1101 H.R. 2332

  • FY2025 Medicare/Medicaid

    Potential payment and delivery innovation models; H.R. 1708/S. 1087, the Rebuild Americas Health Care Schools Act; Medicaid funding and budget reconciliation; H.R. 1/One Big Beautiful Bill.

    H.R. 1708 S. 1087 H.R. 1

  • FY2025 Health Issues

    Change to NIH calculation of F&A rates; National Institutes of Health policies pertaining to child health research including opportunities to address childhood chronic diseases and opportunities within the Make America Healthy Again report and strategy.

  • FY2025 Budget/Appropriations

    FY 26 budget and funding for the National Institutes of Health; structural issues of the NIH.

  • FY2025 Health Issues

    NIH, CDC, FDA, Medicaid and DOD issues and funding relating to muscular dystrophy research and programs.

  • FY2025 Trade (domestic/foreign)

    Application of antidumping duties

  • FY2025 Health Issues

    Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.

The specific issues and bills Faegre Drinker Biddle & Reath LLP reported lobbying on, newest first. Bill references that CivicGate tracks link to the bill; others are shown as reported.